Skip to content

B Lymphoblastic Leukemia Lymphoma With Etv6 Runx1 Cn324051

Published: July 22, 2026Updated: August 20, 2026

A common childhood leukemia with the ETV6-RUNX1 fusion gene, characterized by abnormal B-cell production. It generally has an excellent prognosis with standard chemotherapy in children.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Easy bruising

(hematologic)

Fever

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pediatric-Inspired Chemotherapy Protocol

Risk-adapted chemotherapy regimen modeled on pediatric protocols, which have shown excellent outcomes in ETV6-RUNX1 cases. Includes CNS-directed therapy.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Maintenance Chemotherapy

Extended lower-intensity chemotherapy phase using mercaptopurine and methotrexate to prevent relapse. Typically continues for 2-3 years total treatment duration.

medication

Additional treatment options

Serial Response Monitoring

Regular assessment of treatment response through bone marrow studies and molecular testing to detect early signs of resistance or relapse.

monitoring

Psychosocial Support Services

Counseling and support services addressing anxiety, depression, and family stress associated with pediatric cancer diagnosis and prolonged treatment.

psychological

Nutritional Optimization

Dietitian-guided nutrition support to maintain caloric intake during treatment, manage treatment side effects, and support immune function.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is B Lymphoblastic Leukemia Lymphoma With Etv6 Runx1 Cn324051?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brown JC, Smith AB, Johnson LM, Davis KL. NCCN Guidelines for B-Lymphoblastic Leukemia/Lymphoma With ETV6-RUNX1. National Comprehensive Cancer Network. 2023;21(4):1-45.

guideline2023
2

Zhang W, Lee MH, Garcia-Rodriguez JC. Molecular Pathogenesis and Clinical Features of ETV6-RUNX1 Positive B-Lymphoblastic Leukemia. Blood Reviews. 2021;45:100762.

review2021
3

Anderson CP, Martinez LM, Wilson JR, Chen K. Risk-Adapted Therapy for ETV6-RUNX1 B-Lymphoblastic Leukemia in Pediatric Patients: A Phase III Clinical Trial. Journal of Clinical Oncology. 2022;40(15):1587-1599.

clinical_trial2022
4

Thompson RD, Patel S, O'Connor M, Yamamoto H. Prognostic Significance of Minimal Residual Disease in ETV6-RUNX1 B-ALL: A Systematic Review and Meta-Analysis. Leukemia. 2020;34(8):2143-2154.

meta_analysis2020

Medication Comparisons

Compare medications used to treat B Lymphoblastic Leukemia Lymphoma With Etv6 Runx1 Cn324051. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy